Removal of the interplane septa and configu ration of a typical multi slice PET scanner to accept all possible coincidence lines of response leads to a fivefold increase in sensitivity. This can be of value in regional CBF studies using bolus 150-labeled water injections, al lowing the injected dose to be reduced by a factor of 4, while maintaining the same number of noise equivalent counts. Thus, for a given cumulative dose limit, four times as many studies can be performed in a single sub ject. Data from the three-dimensional Hoffman brain phantom, closely matched to count rates seen in human studies, show that for an identical cumulative dose, the
The detection of focal changes in regional cere bral blood flow (rCBF) using '50-labeled water and positron emission tomography (PET) is a powerful technique for noninvasively investigating the rela tionships between structure and function in the hu man brain. By acquiring multiple studies, under resting conditions and during the performance of carefully defined activation tasks, the difference be tween control and activation images can be used to identify areas of the brain involved in the perfor mance of the task (Fox et aI., 1984; Mazziotta et al. , 1985) . These studies are currently limited by the relatively poor counting statistics of PET data sets, although biological variation may also play an im-noise in subtraction (stimulus minus baseline) images can be reduced by a factor of 2 using three-dimensional data acquisition, with appropriate fractionation of the dose. This improvement is dependent on axial position due to the sensitivity characteristics of three-dimensional scans; however, there is a significant gain in the signal-to-noise ratio (SIN) in all image planes. Studies performed in a human subject demonstrate how the factor of 2 gain in SIN leads to improved detectability of activation sites in PET subtraction images. Key Words: Positron emission tomography-Cerebral blood flow-Activation-Three dimensional imaging.
portant role in placing limits on the detectability of activation sites.
In order to minimize radiation exposure to nor mal volunteers, cumulative dose limits for 150_ labeled water are generally limited to 250--350 mCi. A typical two-dimensional (2-D) imaging protocol would consist of six bolus injections, each of 50 mCi, with an interstudy interval of 15 min. This dose maximizes the counting statistics in each indi vidual study and typically leads to deadtime of up to 50% and a randoms fraction of 20% when using the ECAT-831 neuro PET scanner (CTI Inc.lSiemens, Knoxville, TN, U.S.A.). PET scanning commences when the bolus reaches the brain, and images are acquired over a 70 s time frame, which maximizes the detectability of focal flow changes with the ECAT-831 scanner (S. Grafton, unpublished data). The integrated data set is roughly proportional to the rCBF over the range of flows commonly en countered in the human brain (Herscovitch et aI., 1983) . In a typical paradigm, three studies are per formed under resting conditions, and the other three while performing the activation task. After global normalization, the sum of the control data sets is subtracted from the sum of the activation data sets to produce a pixel-by-pixel map of CBF changes. Regions showing a significant change in rCBF are identified and related to the performed task.
For some tasks, the stimulation produces large and widespread changes in rCBF that are easily identified. In many situations, however, the changes are more subtle, and PET subtraction im ages can be ambiguous due to the statistical limita tions of 150-labeled water studies. The noisy nature of these studies is due to the short imaging time, count-rate limitations, and the relatively poor sen sitivity of PET scanners operating in the standard slice-oriented (two-dimensional) mode (less than 1% of the annihilation photon pairs are detected). There is also a further propagation of noise due to the subtraction process. One approach to detecting more subtle changes has been to average data across several subjects (Fox et aI., 1988; Friston et aI., 1989) . However, this method is susceptible to intersubject variations in gyral anatomy and does not account for functional differences in the way tasks may be handled by different subjects. Group averaging also leads to some deterioration in spatial resolution due to the transformations that have to be applied before images from different subjects can be matched.
By removing the interplane septa from multi slice PET scanners and reconfiguring the system to ac cept coincidences between all combinations of de tector rings (three-dimensional imaging mode), it is possible to increase significantly the sensitivity of multislice PET scanners, particularly in the central imaging planes (Dahlbom et aI., 1989; Townsend et aI., 1991; Cherry et aI., 1991) . At high count rates, such as those encountered in bolus 150-labeled wa ter studies, it is generally not possible to improve image statistics greatly by three-dimensional imag ing, because the system is already close to count rate saturation. However, due to the extra sensitiv ity of three-dimensional data acquisition, equivalent counting statistics can be obtained with one-quarter of the injected dose used in conventional two dimensional imaging (Cherry et aI., 1991) . This al lows many more studies to be performed within a subject for a given cumulative dose limit, thus im proving the signal-to-noise ratio (SIN) of subtrac tion images and the accuracy of blood flow esti mates, without resorting to multiple subject averag ing. A further important benefit of performing many trials is that the noise due to random biological flow variations will be reduced. The improvement in SIN, apart from giving increased confidence in the difference images, will allow the images to be re-constructed at a higher spatial resolution, thereby producing better localization of blood flow changes. The one major drawback of three-dimensional PET imaging, namely the large increase in scatter frac tion, has a minimal effect in difference images, be cause the scatter contribution is virtually identical for control and activation studies and will cancel out upon subtraction. However, the increased scat ter fraction does result in a small underestimation of the percentage change in blood flow that would jus tify the use of a scatter correction in circumstances where the exact value is of importance.
The aim of this study was to investigate the use of three-dimensional PET imaging to improve the SIN in rCBF activation studies after bolus injections of 150-labeled water. Using the three-dimensional Hoffman brain phantom (Hoffman et aI., 1990) , it is possible to set up realistic and well-controlled ex periments that closely approximate the activity dis tribution and count rates of in vivo 150-labeled wa ter PET studies. By imaging the phantom using two and three-dimensional acquisition modes over a wide range of activities, the optimum protocol for a given cumulative dose limit can be derived. Inflat able balloons can be placed in the phantom to rep resent activation sites, and an index of detectability derived for two-and three-dimensional imaging pro tocols. In this way, two-and three-dimensional im aging protocols can be designed that optimize the SIN in PET difference images, leading to improved detection of activation sites in many of the more complex paradigms that are currently under inves tigation for mapping functional pathways in the brain.
MATERIALS AND METHODS
All data were acquired on the ECAT 831/08-12 PET system. This tomograph has eight detector rings with a diameter of 64 cm, each containing 320 bismuth ger manate crystals (Hoffman et aI., 1987 (Hoffman et aI., , 1988 . Each data set consists of 15 image planes, with a slice-to-slice sep aration of 6.75 mm, leading to an axial field of view of approximately 10 cm. The interplane tungsten septa are 16 cm tall and 1 mm in width. The scanner has been modified to allow the septa to be manually removed in under 5 min (Cherry et aI., 1991) . System software allows the scanner to be reconfigured to acquire a full three dimensional dataset consisting of coincidence events be tween all detector rings. Images were reconstructed by filtered backprojection, in the three-dimensional case us ing a fully three-dimensional reconstruction algorithm with a maximum ring difference of ±5 (Defrise et aI., 1990; Cherry et aI., 1992) . All studies employed a Shepp Logan filter, rolled off at the Nyquist frequency (0.16 mm -1 ) , leading to an image resolution of 6.2 mm at the center of the field of view. Attenuation correction was carried out using a calculated correction based either on prior knowledge of the attenuating medium (for phantom studies) or using edge detection on the emission sino grams (Bergstrom et aI., 1982; Siegel and Dahlboom, 1992 ). An attenuation coefficient of t.L = 0.095 cm -I was ass � med for brain tissue and phantom materials (water, luclte) and t.L = 0.151 cm -I for the skull.
EXPERIMENTS

Calibration of phantom concentration with injected dose
In order to calibrate the three-dimensional Hoffman brain phantom to the injected dose for in vivo studies two-dimensional count-rate data from five normal volun :
teers (four male, one female, age range of 22-41 years) were examined. Informed consent was obtained from all subjects prior to scanning, and the protocol approved by the Human Subject Protection Committee. Each volun teer was injected with 50 mCi of ISO-labeled water on six occasions and true and accidental count rates monitored as a function of time. Using a previously derived scatter fraction of 16% (Cherry et aI., 1991) , noise equivalent count (NEC) rates were also calculated. This reflects the number of true events recorded, corrected for the pres ence and subtraction of scattered and random events (Strother et al., 1990) . Subsequently, 10 mCi of [18F]fluorodeoxyglucose (18-FDG) was placed in the three-dimensional brain phantom and count rates monitored as the activity decayed. The activity level that gave count rates most consistent with the human volunteer data was established and taken to correspond to an injected dose of 50 mCi. The derived calibration factor allows phantom concentrations to be directly related to the injected dose of in vivo studies. Figure 1 shows count rates as a function of time for a typical ISO-labeled water study in a human subject. The period over which the counts are integrated to form the blood flow image is also indicated, showing that true, random, and NEC rates can be approximated by a con stant at this time. Thus, brain phantom studies acquired over 70 s with a constant activity will closely approximate an in vivo blood flow study if the appropriate activity concentration is used. The brain phantom matched aver age count rates found in the human volunteers most closely when a gray matter activity concentration of 3.8 t.LCi/cc was used. Count-rate data from the phantom at this concentration and from the human volunteers is shown in Table 1 . Because the phantom is somewhat larger (20 cm diameter) than the average human head, the coincidence to the singles event ratio is smaller than it would be in vivo. Correspondingly, the randoms rate and the deadtime are higher in the phantom study for a given NEC rate. However, all of the count rates in the phantom study fall well within the normal range seen in vivo. This calibration allows the concentrations used in subsequent phantom experiments to be converted to injected dose, using a multiplicative factor of 13,158 cc.
Noise as a function of injected dose
The three-dimensional Hoffman brain phantom was filled with 18F at a concentration of 6.5 t.LCilcc. This was estimated from the calibration procedure above to corre spond to an injected dose of 85 mCi. As the activity in the phantom decayed, two-and three-dimensional PET data sets were acquired every 20 min, until the concentration corresponding to an injected dose of 0.5 mCi was reached. At each acquisition point, two 70 s scans were acquired, the only difference between them being due to statistical fluctuations.
At the end of the study, all of the two dimensional data sets were summed and reconstructed to produce a high statistics two-dimensional image of the brain phantom. By taking the histogram of this image, pixels representing gray matter were identified and a template produced. This template was applied to all data sets (both two and three dimensional) to insure that only pixels representing gray matter were included in the subsequent analysis. Since blood flow activation occurs predominantly in gray mat ter, we chose to examine the SIN characteristics in these regions, rather than averaging across gray and white mat ter pixels, which have significantly different variances.
The mean value of each image data set was set to 100 and subtraction images calculated from the paired mea surements at each activity point. Since each pair of im ages will be the same, within statistical variations, the standard deviation of gray matter pixels in the difference image (SD p iJ was taken as a measure of the average noise due to counting statistics. All gray matter pixels in the imaging volume were included in the calculation of SD .
• � x ' Plottmg SD p ix as a function of concentration for both twoand three-dimensional studies allowed the optimum in jected dose for a single study to be identified.
The SD p ix of gray matter in the brain phantom is shown in Fig. 2 as a function of equivalent injected dose (using the calibration factor above) for both two-and three dimensional studies. As expected, the noise level de creases as the injected dose increases. Eventually, ran dom events and deadtime start to dominate system per forma � c � , � hich results in a deterioration of SIN for large bolus mJectlons. The concentration at which the noise reaches its lowest level in the subtracted images corre sponds to an equivalent injected activity of 54 mCi in two- dimensional datasets and 14 mCi in three-dimensional datasets. At these activities, the gray matter pixel stan dard deviations are 28% (two dimensions) and 23% (three dimensions). Thus, three-dimensional data acquisition will provide a modest reduction in statistical noise for a single pair of studies performed at the optimum injected dose on this particular scanner. The key feature, how ever, is that the small improvement in three-dimensional studies is achieved using approximately one-quarter of the injected dose of the two-dimensional study.
Noise as a function of dose fractionation
Because of the need for improved image statistics, 150_ labeled water studies rarely consist of a single pair of activation and control studies. The total number of stud ies that can be performed in an individual is determined by the cumulative dose limit, which is typicall y set at 3 � 0 mCi. The aim of this calculation was to predIct SD p ix In the difference images for a total dose of 300 mCi, deliv ered in different fractions, but split equally between con trol and activation trials (i.e., 150 mCi for control studies and 150 mCi for activation studies). Based on the SD p ix for a single pair of studies at different injected doses (D) obtained above, it is possible to estimate SD p ix for a cu mulative dose of 300 mCi as SDpix(300 mCi) = SD p ix(D)/Y( 150ID)
assuming that the noise adds in quadrature.
As an experimental validation of this extrapolation pro cess, 70 s brain phantom studies were acquired with ac tivities corresponding to a 12.5 mCi injected dose (three dimensions) and a 50 mCi injected dose (two dimensions). Twenty-four trials were performed for the three dimensional study, and 6 for the two-dimensional study, giving an equivalent cumulative dose of 300 mCi in each case. Data sets were split into two groups, summed, nor malized, and then subtracted to produce difference im ages. Gray matter pixel standard deviation . s were calcu lated as described above and compared WIth the values predicted by Eq. (1). Figure 3 shows how the SD p ix is expected to vary as a function of the way in which the dose is split for a total dose limit of 300 mCi [based on Fig. 2 and Eq. 0)]. For example, if 50 mCi is injected each time, six studies (three control, three activation) can be performed before the dose limit is reached. If 12.5 mCi is injected each time, then 24 injections (12 control, 12 activation) are possible. SD· was measured for these particular protocols using pIX the Hoffman brain phantom and were found to be 18% for the two-dimensional data set and 9% for the three dimensional data set. These values are in good agreement with the values predicted using Eq. (1) (Fig. 3) . The re sults demonstrate that the lowest noise levels are ob tained by splitting the total dose into many small frac tions. This is intuitively obvious, since few counts are lost due to deadtime by using low doses, and there are only a small number of random events. Thus, the number of NECs obtained per unit dose are maximized. Now the real advantage of three-dimensional data acquisition be comes apparent, because we have seen that similar noise levels are obtained using one-quarter of the two dimensional dose. Therefore, four times as many studies can be performed in three dimensions for the same cu mulative dose, leading to a predicted improvement of a factor of 2 in SIN over and above that already seen for a single study.
Attenuation of signal due to scatter
So far, we have been primarily concerned with the noise level in two-and three-dimensional difference im ages. However, the detectability of an activation site also depends critically on the signal it produces in a PET im age, and this signal can be affected by the prese � ce of background counts due to scattered events. In partIcular, the apparent magnitude of the activation, when expressed as a % change, is reduced in the presence of a high scatter background. To estimate the magnitude of this effect, re gions of interest (ROIs) were placed over scattered events reconstructed within the physical edges of the phantom, but just outside the active section of the brain phantom. Counts from the scatter ROI were compared with the average count density for cortical gray matter. Since the scatter regions were defined immediately adjacent to cor tical gray matter, the scatter contribution under the cor tical regions can be assumed to be similar. Knowing the fraction of reconstructed counts in cortical gray matter pixels that are due to scatter, it is possible to estimate the reduction in the observed % change for a given activation magnitude.
From the ROI analysis, the scatter ratio (scatter/trues) (1), the pixel standard deviations in Fig. 2 , and a cumulative dose limit of 300 mei. The boxes represent repeated mea surements on the brain phantom that were used to validate the calculated estimates.
in cortical gray matter pixels was estimated to be 4% in the two-dimensional images and 15% in the three dimensional images. Therefore, if activation changes the true counts from T to AT, the apparent magnitude .:ls of the activation in the presence of scatter S is related to the true magnitude .:l (AT -T)/T by (AT + S) -(T + S) .:l .:l s = (T + S)
Inserting the values for the scatter ratio in two and three dimensions gives .:ls = 0.96 .:l and .:ls = 0.S7 .:l, respec tively. The ratio of the estimated activation magnitude is .:ls(three dimensions)/.:ls(two dimensions) = 0.91. There fore, three-dimensional imaging on the ECAT -S3\ is ex pected to lead to a 9% underestimation of the activation magnitude relative to two-dimensional imaging. Similar underestimation will also occur for decrements in flow.
Simulated activation study using the Hoffman brain phantom The brain phantom was scanned using the standard 6 x 50 mCi two-dimensional imaging protocol and a three dimensional imaging protocol consisting of 24 trials of 12.5 mCi, thus simulating a complete activation study with a cumulative dose of 300 mCi. For three-dimensional studies, the protocol was based on the results of the pre vious three sections together with a consideration of fea sibility for human studies.
The activity of IS-FDG in the phantom was appropriate for the injected dose being simulated (4 j.LCilcc for two dimensional studies, 1 j.LCilcc for three-dimensional stud ies), and 70 s data sets acquired for each trial. One-half of the trials were performed in a "resting" state, and the other half after the addition of five "activation" sites to the phantom. These activation sites consisted of small balloons filled at a concentration 25% higher than sur rounding gray matter and placed in both cortical and sub cortical gray matter towards the center of the axial field of view. The volumes of the balloons ranged between 3.0 and 4.5 cc and were distributed within the phantom to conform three dimensionally to gray matter boundaries. A high statistics two-dimensional dataset (20 x 106 counts/plane) of the brain phantom with activation sites was also acquired from which a template containing gray matter pixels was created as described. This template was further segmented into the activation sites and nonacti vated gray matter.
Two-and three-dimensional subtraction images were formed from the summed control and activation data sets. The reconstructed images were smoothed using a Gaus sian kernel of width 5 mm prior to subtraction. A 1 cm circular ROI was placed over the activation sites in the two-and three-dimensional subtracted images and the mean value taken to represent the signal. A measure of the noise was obtained by taking the standard deviation of 20 identically sized regions spread throughout nonacti vated gray matter and in the same plane as the activation site. SIN values were then calculated and taken as a mea sure of the detectability of each activation site.
The additional oblique lines of response acquired in three-dimensional data sets cause the sensitivity to be peaked towards the center of the field of view (Cherry et aI., 1991) . This effect is very pronounced in the axial J Cereb Blood Flow Metab. Vol. 13, No. 4, /993 direction, where there is an fivefold difference in sensi tivity between the central and outermost imaging plane. Transaxially, the effect is much smaller, with the sensi tivity changing by less than 20% across the diameter of the brain. In two-dimensional data sets, the scanner also exhibits axial variations in sensitivity, with the sensitivity being higher in the even numbered planes than in the odd numbered planes, because each even numbered plane projection element is defined from two lines of response . In order to examine the issue of varying sensitivity with axial position, gray matter pixel-to-pixel standard devia tions (proportional to statistical noise) were obtained from each plane of the subtracted phantom images. Re gions containing the balloon activation sites were ex cluded from this analysis using the template .
The activation study performed in the brain phantom confirms that a combination of three-dimensional data ac quisition and increased dose fractionation leads to a sig nificant improvement in SIN in 150-labeled water studies. U sing a realistic three-dimensional imaging protocol equivalent to 24 studies following the injection of 12.5 mCi of 150-labeled water, there is a clear improvement in image quality in the summed control and activation images (Fig. 4) , compared with the standard two-di mensional imaging protocol. Figure 4 also shows images of % change. In the three-dimensional study, the five ac tivation sites are clearly visible and there are no other large regions showing activation above the 10% thresh old. In the two-dimensional study, for the same thresh old, the activation sites are also visible; however, due to the increased noise level in the two-dimensional images, many other unactivated regions also reach the threshold. Thus, changes at the 10% level are less significant in the two-dimensional studies than in the three-dimensional studies. The quantitative improvement in SIN for each activation site in the phantom is shown in Table 2 . The three-dimensional protocol shows an average SIN in crease of a factor of I.S over the two-dimensional proto col.
The balloons were placed towards the center of the axial field of view (planes 6-10), where the sensitivity of the three-dimensional data set is maximized. This is a reasonable approach since areas of interest in activation studies are often known a priori and can be placed in the center of the scanner. It should be noted, however, that the three-dimensional imaging protocol leads to improved SIN throughout the entire field of view, as demonstrated by Fig. 5, which shows a plot of SDpix as a function of distance from the center of the axial field of view.
In vivo comparisons of two-and three-dimensional studies Two-and three-dimensional activation studies were carried out in a right-handed normal male subject using visual stimulation in order to verify the findings of the phantom experiments. Informed consent was obtained prior to the study under the guidelines of the UCLA Hu man Subject Protection Committee. A total cumulative dose of 160 mCi was injected, split equally between the two-and three-dimensional studies. A dose of 40 mCi was used for the two-dimensional studies (two trials; one stim ulation, one control) and a dose of 10 mCi was used for the three-dimensional studies (eight trials; four stimula tions, four controls). All ten trials were performed on the same day, alternating between control and stimulation states. A custom foam head holder (Smithers, Akron, a) plane 6 plane 7 plane 8 \.
-. . .
'r
;. r' OH, U.S.A.) was used in order to keep head movement to a minimum. A left-hemifield alternating black-and-white checker board pattern was used for visual stimulation. The pattern was displayed on a television monitor (27.5 cm wide by 21 cm high) located at a distance of 60 cm from the subject's eyes. The individual elements of the pattern measured 1.875 by 1.5 cm. The pattern reversed at a frequency of 8.2 Hz, which is close to the rate shown previously to induce maximal increases in rCBF (Fox and Raichle, 1985) . The monitor was divided into left and right sections by a central, 2 cm wide, black strip. During the stimula tion task, only the left side of the monitor was illuminated with the pattern, and the right half of the monitor was dark. In the control condition, the entire screen was a homogeneous stationary gray color. During both control and stimulation, the subject was instructed to fixate on a small white dot at the center of the dividing strip halfway down the length of the screen. Visual fixation on this dot and presentation of the pattern was established 20 s prior to tracer injection, and continued for the duration of the study.
The subject was positioned such that the visual cortex appeared in image planes 10-12 (15 to 30 mm from the axial center of the scanner) and data sets acquired over a period of 90 s following injection. Taking into account the time required for the bolus to reach the brain (20-30 s), this results in integration of ISO-labeled water uptake over a period of 60-70 s, which has been shown to be optimal for maintaining linearity with blood flow, while maximizing counting statistics on the ECAT -83 1 (S. Grafton, unpublished data). Studies were reconstructed using filtered backprojection with a Shepp-Logan filter cutoff at the Nyquist frequency. This leads to a recon structed resolution of 6.2 mm. A calculated attenuation correction, based on edge detection in the emission sino gram, was applied to all data sets (Bergstrom et aI., 1982; Siegel and Dahlbom, 1992) . Summed control and acti vation data sets were produced for the three-dimensional study. Prior to subtraction, the two-and three-dimen sional data sets were globally normalized (using normal ization factors derived from the mean value of all brain pixels in the data set) and smoothed with a Gaussian filter to give a resolution of 8.5 mm in the % change images. A measure of the noise in the two-and three-dimensional % change images was obtained using 16, 8 mm diameter activation 2-D
3-D
ROIs placed over unactivated gray matter areas as de scribed earlier for the brain phantom data. Identical re gions were used for the two-and three-dimensional data sets. Figure 6 illustrates that the significant gains in SIN seen in the brain phantom studies are maintained in human studies, despite the confounding factors of subject move ment and variability of response. The task was predicted to give a response in the right striate cortex, which was positioned 15 to 30 mm off center axially and 7 cm off center transaxially and was therefore not particularly op timized for three-dimensional data acquisition. Even so, the activation focus can even be identified by comparison of the un subtracted and unsmoothed three-dimensional data sets. In the two-dimensional images, for the same dose, there are insufficient statistics to support any con clusion about the activation focus.
The % change images (smoothed to a resolution of 8 mm) demonstrate the improvement in SIN even more dra matically. ROI analysis across unactivated gray matter reveals noise values of 5.4% for the two-dimensional study and 2.9% for the three-dimensional study, thus in dicating a SIN gain of close to a factor of 2 for three dimensional studies. This is in close agreement with the phantom studies. In the three-dimensional images, the right striate cortex shows a uniform 20% increase in sig nal that is several standard deviations above background.
In the two-dimensional study, signal changes of between 10 and 50% (average of 21%) are seen across the same region due to the poor statistical nature of the data and many "false" activation foci are seen (principally in white matter, where the standard deviation is higher). This study is a powerful demonstration of the improve ment in SIN due to three-dimensional acquisition and re construction using the same cumulative dose, the same control 0/0 change FIG. 6. Two-(2 x 40 mCi) and three-dimensional (8 x 10 mCi) studies from a human subject reconstructed at 6.2 mm resolution with and without left hemifield visual stimulation using a reversing checkerboard. Data sets were smoothed to 8.5 mm prior to calculating the % change images at far right. A 20% activation in the right striate cortex can be clearly seen in the three dimensional data set, but is lost among the noise in the two-dimensional data set.
reconstruction filter, and the same processing as a stan dard two-dimensional study.
DISCUSSION
Combining three-dimensional data acquisition and reconstruction with appropriate dose fraction ation leads to significant improvements in SIN in PET subtraction images of CBF. This has been demonstrated using realistic activity concentrations and activity distributions by using the three dimensional Hoffman brain phantom and cross calibrating to actual human studies. It should be noted that because the brain phantom is somewhat larger than the average head (20 cm diameter), these studies will slightly underestimate SIN improve ments in three-dimensional studies relative to the two-dimensional studies because of scatter consid erations. The absolute SIN values will also be crit ically dependent on the magnitude and extent of the activation, the size and shape of applied ROls, the reconstruction filter, and any other image process ing that is performed (Fox, 1991) .
In this study, a three-dimensional imaging proto col using small doses led to improved SIN through out the field of view compared with our standard two-dimensional imaging protocol. It is important to point out that two-dimensional studies would also benefit significantly from the use of more trials with smaller doses (Fig. 3) and that the gain is there fore not entirely due to three-dimensional acquisi tion. However, it can also be argued that even higher SIN could be obtained by fractionating the three-dimensional dose still further, although this leads to an inpractical number of studies for most purposes. Future improvements in scanner sensitiv ity (by increasing the axial field of view) and reduc tions in dead time could lead to an additional factor of 4 to 6 in sensitivity for three-dimensional 150_ labeled water studies.
An unrelated advantage of performing many trials is that effects due to random biological variation will be diminished. Thus, the chance of detecting blood flow increases that are unrelated to the task at hand are reduced. A potential disadvantage of the many trials approach is the requirement of an accu rate method for repositioning the subject if the study is spread over several sessions. This is par ticularly important in tomographs that exhibit a dif ference in transverse and axial resolution, since, here, differential partial volume effects can signifi cantly increase the noise in subtraction images if one of the data sets has to be resliced (Woods et aI., 1992) . In this situation, accurate realignment of the brain is required prior to scanning in order to max imize the SIN in the subtraction images.
Three-dimensional PET data sets exhibit two im portant properties that should be considered when performing studies. Firstly, the sensitivity, and hence the SIN, is peaked towards the center of the axial field of view, so structures of interest, if known a priori, should be positioned accordingly. Despite this feature, SIN is improved across the whole imaging volume for a given cumulative dose (Fig. 5) . Second, the presence of more scattered events leads to a small (9% for the ECAT-831) at tenuation in the apparent magnitude of an activation site, relative to two-dimensional studies.
Our current protocol at UCLA is to perform up to 18 trials in each subject, using 10 mCi injections and three-dimensional data acquisition. Typically, six trials will be performed in a single session. The sub ject is realigned at the beginning of each session using information from a short transmission scan combined on-line repositioning using the method developed by Woods et al. (1992) , which rapidly computes all of the necessary gantry and bed posi tion changes. This method has proven to be highly accurate and data sets acquired on different days require little or no realignment prior to summation.
Three-dimensional data acquisition and recon struction is now in routine use for activation studies at UCLA, and we have performed over 200 such studies. By greatly improving image statistics and reducing the effects of biological variation, it at tacks the two central issues that currently limit ac tivation studies. Within a single subject, it has now become possible to map the response to a single task with unprecendented statistics, or, alterna tively, to map the response to a whole battery of tasks without increasing the cumulative dose to the subject.
